Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Diversity in Medical Affairs and the Power of Networking
Summary
In this episode, Tom Caravela welcomes guests Rachel Kennedy, Lashondra Taylor, and Nirav Shah to discuss the formation and mission of DEMA. They explore the transformative power of networking, sharing Rachel's inspiration behind DEMA and how to engage with the organization. The conversation includes networking success stories and valuable advice for new MSLs and job seekers. The guests outline DEMA's current initiatives and future plans, highlighting upcoming events. The episode concludes with updates from Tom and expressions of appreciation for the listeners' support.
My guests today are Rachel Kennedy, LaShaundra Taylor, and Nirav Shah from DiMA (Diversity in Medical Affairs) and we discuss the story of DiMA and the power of networking.
In this episode we discuss:
- Intro of Rachel, LaShaundra, and Nirav
- The story of how the DiMA group was formed
- What is the mission and how can people join or get involved?
- Their advice for medical affairs professionals on networking and how it can advance their career
- Examples of how networking has helped them in their careers.
- Other advice to those that are looking to build a career in Medical Affairs
networking in medical affairs, DEMA mission, career advancement tips, medical affairs professionals, diversity in medical affairs
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Patrina Pellett
Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Time Audit: YOUR Strategy for Time Management Success
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO